Also known as Tagamet
Cimetidine INN is a histamine H2-receptor antagonist that inhibits stomach acid production. It is largely used in the treatment of heartburn and peptic ulcers. It has been marketed by GlaxoSmithKline (which is selling the brand to Prestige Brands) under the trade name Tagamet (sometimes Tagamet HB or Tagamet HB200). Cimetidine was approved in the UK in 1976 and was approved in the US by the Food and Drug Administration for prescriptions starting January 1, 1979.Source: Wikipedia
Estimated Total Cost: $8.42 for an average of 28 days supply
Patients are most commonly prescribed cimetidine to treat allergy, allergic reaction, lung cancer, and drug reaction.